Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13


Thromboembolic events and haematological diseases: a case of stroke as clinical onset of a paroxysmal nocturnal haemoglobinuria.

Granata G, Izzo T, Di Micco P, Bonamassa B, Castaldo G, Viggiano VG, Picillo U, Castaldo G, Niglio A.

Thromb J. 2004 Nov 11;2(1):10.


Respiratory changes in transvalvular flow velocities versus two-dimensional echocardiographic findings in the diagnosis of cardiac tamponade.

Materazzo C, Piotti P, Meazza R, Pellegrini MP, Viggiano V, Biasi S.

Ital Heart J. 2003 Mar;4(3):186-92.


Pain experienced by patients hospitalized at the National Cancer Institute of Milan: research project "towards a pain-free hospital".

Ripamonti C, Zecca E, Brunelli C, Groff L, Boffi R, Caraceni A, Galeazzi G, Martini C, Panzeri C, Saita L, Viggiano V, De Conno F.

Tumori. 2000 Sep-Oct;86(5):412-8.


A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapy.

Rivoltini L, Squarcina P, Loftus DJ, Castelli C, Tarsini P, Mazzocchi A, Rini F, Viggiano V, Belli F, Parmiani G.

Cancer Res. 1999 Jan 15;59(2):301-6.


Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.

Rivoltini L, Radrizzani M, Accornero P, Squarcina P, Chiodoni C, Mazzocchi A, Castelli C, Tarsini P, Viggiano V, Belli F, Colombo MP, Parmiani G.

J Immunol. 1998 Aug 1;161(3):1220-30.


Interaction of NF-kappaB and NFAT with the interferon-gamma promoter.

Sica A, Dorman L, Viggiano V, Cippitelli M, Ghosh P, Rice N, Young HA.

J Biol Chem. 1997 Nov 28;272(48):30412-20.


Stat1 is induced and activated by all-trans retinoic acid in acute promyelocytic leukemia cells.

Gianni M, Terao M, Fortino I, LiCalzi M, Viggiano V, Barbui T, Rambaldi A, Garattini E.

Blood. 1997 Feb 1;89(3):1001-12.


Retinoic acid-induced transcriptional modulation of the human interferon-gamma promoter.

Cippitelli M, Ye J, Viggiano V, Sica A, Ghosh P, Gulino A, Santoni A, Young HA.

J Biol Chem. 1996 Oct 25;271(43):26783-93.


Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes.

Rivoltini L, Barracchini KC, Viggiano V, Kawakami Y, Smith A, Mixon A, Restifo NP, Topalian SL, Simonis TB, Rosenberg SA, et al.

Cancer Res. 1995 Jul 15;55(14):3149-57.


Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun.

Cippitelli M, Sica A, Viggiano V, Ye J, Ghosh P, Birrer MJ, Young HA.

J Biol Chem. 1995 May 26;270(21):12548-56.


In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5.

Rivoltini L, Viggiano V, Spinazzè S, Santoro A, Colombo MP, Takatsu K, Parmiani G.

Int J Cancer. 1993 Apr 22;54(1):8-15. Erratum in: Int J Cancer 1993 Jul 9;54(5):887.


[Several cases of intestinal duplications].

Battisti C, Cairoli G, Giuntoli M, Viggiano V.

Minerva Pediatr. 1978 Mar 31;30(6):491-9. Italian. No abstract available.


Supplemental Content

Loading ...
Support Center